United Orthopedic (4129) — Cash Flow Reinvestment Rate
United Orthopedic (4129) has a Cash Flow Reinvestment Rate of 1.13x as of December 2025, reinvesting NT$252.00 Million (capex NT$252.00 Million plus investments NT$-1.00K) from operating cash flow of NT$223.65 Million. Check 4129 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
United Orthopedic Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for United Orthopedic across 11 annual periods. Explore long-term investment intensity of United Orthopedic to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for United Orthopedic (2015–2025)
Year-by-year capital reinvestment analysis for United Orthopedic. For live market cap and broader valuation context, see United Orthopedic (4129) total market value.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.75x | NT$768.28 Million | NT$1.03 Billion | NT$761.23 Million | ▼ -9.0% |
| 2024 | 0.82x | NT$590.40 Million | NT$717.29 Million | NT$589.33 Million | ▼ -68.1% |
| 2023 | 2.58x | NT$1.03 Billion | NT$398.43 Million | NT$557.53 Million | ▲ +14.6% |
| 2022 | 2.25x | NT$766.57 Million | NT$340.79 Million | NT$386.21 Million | ▲ +194.6% |
| 2021 | 0.76x | NT$255.53 Million | NT$334.64 Million | NT$227.21 Million | ▲ +18.9% |
| 2020 | 0.64x | NT$309.37 Million | NT$481.65 Million | NT$231.79 Million | ▼ -38.8% |
| 2019 | 1.05x | NT$516.74 Million | NT$492.45 Million | NT$299.41 Million | ▼ -96.6% |
| 2018 | 31.27x | NT$388.10 Million | NT$12.41 Million | NT$386.17 Million | ▼ -84.5% |
| 2017 | 202.10x | NT$585.89 Million | NT$2.90 Million | NT$584.43 Million | ▲ +3131.1% |
| 2016 | 6.25x | NT$1.12 Billion | NT$179.03 Million | NT$394.53 Million | ▲ +189.7% |
| 2015 | 2.16x | NT$545.61 Million | NT$252.75 Million | NT$207.93 Million | — |